Vitamin D and Cognitive Function After 45
On January 22, 2026, researchers published a new study in the journal BMJ Open examining how vitamin D supplement use relates to cognitive functioning in older adults. The observational analysis by Hua, Lam, Mok and Cheung found that older adults with already adequate vitamin D status who used supplements experienced slightly faster cognitive decline than non-users.
The Study Cohort
The researchers based their analysis on data drawn from the United States Health and Retirement Study. They looked specifically at information collected during waves 12 through 15 of the survey. The resulting cohort included 5,065 participants who were monitored over a period of six years. This group provided a substantial data set for tracking long-term health outcomes.
The participants had a mean age of 67.5 years. The study included a significant number of women, who made up 61.6 percent of the total group. Among all participants, 39.6 percent reported taking vitamin D supplements. This translated to 2,004 people using the pills during the observation period.
The reported doses typically ranged between 400 and 2,000 IU per day. These amounts represent standard routine use rather than the massive doses sometimes promoted in online longevity protocols. The researchers evaluated the cognitive outcomes using linear mixed models adjusted for multiple covariates. This statistical approach helped them track the rate of change over the six years.
The Clinical Outcomes
The primary results showed a clear difference between those taking supplements and those who did not. Vitamin D supplement users experienced a faster decline in global cognitive function compared with non-users. The between-group difference in the rate of change was negative 0.052 points per year. The researchers reported a 95 percent confidence interval of negative 0.092 to negative 0.013, with a p-value of 0.010.
The data revealed a similar pattern regarding executive function. Users experienced a faster decline in this specific area of mental performance. The between-group difference was measured at negative 0.021 points per year. The 95 percent confidence interval for this outcome was negative 0.037 to negative 0.005, also with a p-value of 0.010.
These findings were heavily dependent on the baseline vitamin D levels of the participants. The reported association was concentrated entirely among participants whose baseline vitamin D status was described as normal, adequate or replete. A sensitivity analysis for this specific group produced a p-value of 0.004.
The results looked very different for people who lacked sufficient vitamin levels at the start of the observation. Among participants classified as vitamin D insufficient or deficient, the study found no statistically significant signal of either benefit or harm. The analysis for this subgroup returned a p-value of 0.826.
Broader Clinical Trials
These findings align with a wider pattern seen in recent clinical trials regarding supplementation. A report on the VITAL trial showed that 2,000 IU of vitamin D3 daily did not significantly slow cognitive decline in adults whose vitamin D levels were already adequate. Taking a daily pill did not provide a protective effect when a deficiency was absent.
A separate report on the VitaMIND trial produced similar results. Supplementation offered no significant benefit over a placebo on the primary cognitive outcome after 24 months. The treatment provided no significant benefit on specific measures like working memory, verbal reasoning and attention. It also failed to improve instrumental activities of daily living, behavior or overall wellbeing.
The VitaMIND researchers confirmed that the physical intervention was successfully delivered to the participants. They noted that vitamin D blood levels did increase in the treatment group over the trial period. This physical change simply did not translate into a significant cognitive benefit.
Many older men find better results when they support their mental fitness through proven lifestyle factors. Medical research consistently shows that structured workouts and active leisure protect cognitive health. Building a foundation of physical capability serves the brain better than hoping a single pill will resolve complex aging challenges.
Interpreting Adequacy Thresholds
Clinical interpretation depends heavily on individual medical history, kidney function, liver health and specific treatment goals. The United States National Institutes of Health Office of Dietary Supplements provides clear baselines for the public. Their guidance states that blood 25-hydroxyvitamin D levels of at least 50 nmol/L, or 20 ng/mL, are considered adequate. This benchmark applies specifically to bone and overall health in healthy individuals.
The same NIH fact sheet lists adult recommended dietary allowances of 15 to 20 micrograms per day. This amount equals 600 to 800 IU depending on a person's age. The NIH adequacy threshold relates primarily to physical markers rather than mental performance. It is not a proven cognitive-protection threshold, meaning higher numbers do not automatically equal better brain function.
The evidence should not be simplified into a claim that vitamin D is bad for the brain. A more defensible interpretation is that routine supplementation for cognitive protection is simply unsupported in older adults who already have adequate vitamin D status. The evidence also should not be simplified into a blanket rule that sun exposure is always better than supplements. Both approaches require careful consideration of individual health profiles and environmental risks.
Understanding Specific Subgroups
The evidence regarding vitamin D is not universally negative across all populations. A 2026 report on a small Sleep Medicine study described better cognitive scores among a very specific group of adults. These participants had mild cognitive impairment along with sleep problems and reported taking at least 5,000 IU of vitamin D daily.
This small study involved a highly specific, high-risk subgroup. The study used an observational design, meaning its findings cannot be used to claim that high-dose vitamin D improves cognition generally. It does suggest that treating clinical vulnerabilities may produce different outcomes than supplementing healthy adults.
Rather than guessing at supplement doses to fix mental fatigue, older men should look at their daily habits first. Quality rest is a foundational requirement for mental clarity. Proper physiological recovery and regular nightly sleep protects executive function far better than high-dose supplements.
Limitations and Context
The central result of the BMJ Open study is an association rather than absolute proof that supplementation caused faster cognitive decline. People who take supplements often differ from non-users in their health status, diet or socioeconomic factors. They may also have prior concerns about their memory that prompt them to buy vitamins. These variables can influence the data in ways that statistical adjustment cannot completely remove.
The study summary notes that the analysis adjusted for multiple covariates. However, it does not list the full set of those adjustments. This omission makes it difficult to assess how much residual confounding might remain in the final numbers. The reported effects were described as mild, and the available source does not translate the annual point differences into an everyday practical measure.
The researchers also did not report the specific cognitive test scales used to measure global cognition and executive function. The available source does not provide sex-specific effect estimates or separate male-only results. The study was not designed to determine whether supplementing people with a clinically confirmed vitamin D deficiency improves cognition. A lack of statistical benefit in the deficient subgroup is not the same as proving that treating a real deficiency has no health value.
Older men often benefit from comprehensive physical routines instead of isolated supplementation. For example, resistance training and brain structure share a clear connection that supports long-term mental capability. Lifting weights and staying active provide robust physiological benefits that single supplements cannot match.
Practical Medical Guidance
The BMJ Open authors concluded that their data do not support vitamin D supplementation to prevent or slow cognitive decline in older adults who already have adequate vitamin D status. They recommended that people focus on maintaining adequate dietary intake and getting moderate sun exposure. They also urged caution about recommending supplements without a clear medical indication.
Nutrition researcher Marion Nestle was quoted in the source coverage discussing alternative approaches to maintaining vitamin levels. She favored short periods of skin exposure to sunlight, particularly in summer, rather than routine reliance on vitamin D capsules. This approach carries its own nuances regarding environmental safety. Safe sun exposure depends heavily on individual skin type, age and current medications.
Latitude and skin-cancer risk also dictate how much sun a person can safely tolerate. The available evidence does not support treating routine vitamin D use as a straightforward brain protection strategy for healthy older men. It also does not establish that supplementation is harmful to every older adult. Men who already take vitamin D should review their reasons and their current dose with a clinician.
Men should not start taking high-dose vitamin D solely because they want sharper focus, better memory or protection against age-related cognitive decline. The BMJ Open findings do not support that strategy in people who already have adequate vitamin D status. Men who are concerned about memory, concentration or executive function should seek a comprehensive medical assessment instead.
Doctors can evaluate patients for sleep problems, depression and medication effects. They can also check for hearing loss, alcohol use, thyroid disease and vascular risk. These are all potentially treatable contributors to mental fatigue that require specific clinical attention. A sensible approach is to maintain adequate vitamin D status through an appropriate diet, ordinary outdoor activity and clinically indicated supplementation.
People with suspected deficiency or limited sun exposure should not stop prescribed treatment based on this observational study. The same advice applies to those managing malabsorption, osteoporosis risk or other medical indications. Readers should place greater emphasis on the broader fundamentals that support independence and physical function, such as regular aerobic activity, metabolic-risk management, social connection and a nutrient-dense diet.
What this changes: This research confirms existing knowledge that routine high-dose vitamin D supplementation offers no established cognitive benefit for older men who already have adequate status, reinforcing that supplements should be reserved for clear clinical indications.
How Everfitguys helps
Relying on random supplementation to prevent age-related cognitive decline often leads men to ignore the daily habits that actually govern mental sharpness. Poor sleep, stress and slower recovery frequently undermine focus over time, and Everfitguys interprets current medical research to help you address these root causes practically without chasing unnecessary pills. Read the research
Sources
Stay sharp
Get stories
The best writing on craft and life, delivered once a week. No noise, just the good stuff.
